Uterine Cervical Neoplasms

Vulvar cancer

Author/s: 
Jennifer Davis, Jacob McGee, Anjali Kulkarni

Vulvar cancer is an underrecognized gynecologic malignant disease. The incidence of vulvar cancer is 2.3 per 100 000 people in Canada, and is increasing with the rising prevalence of human papillomavirus (HPV). More than 90% of vulvar cancers are squamous cell carcinomas (SCC), mostly diagnosed after age 65 years. Vulvar SCC mimics nonspecific inflammation, which often delays diagnosis. Risk factors include advanced age, HPV infection, lichen sclerosis, smoking, immunodeficiency, and pelvic radiation

Human Papillomavirus and Cancer

Author/s: 
Julie R. Barzilay, Sarah Feldman, Alison E. Burke, Emily Ling, Scott Williams, Caren G. Solomon

In this Double Take video from the New England Journal of Medicine, Dr. Julie Barzilay discusses the connection between certain strains of human papillomavirus (HPV) and cancer, as well as the evidence to support the safety and efficacy of the HPV vaccine in reducing the risk of cervical neoplasia. Strategies for discussing the HPV vaccine with patients and families are also reviewed.

Subscribe to Uterine Cervical Neoplasms